Estrella Immunopharma, Inc. (ESLA) earnings
ESLA earnings moved a median of +0.57% by the close. Quarterly and annual ESLA reports and results, each read against the price at its own news timestamp. Back to the ESLA overview →
13 measured ESLA earnings events.
Where these ESLA earnings landedvs 11 measured ESLA earnings reactions
| Middle 50% of ESLA earnings reactions | -2.37% to +4.09% |
|---|---|
| Median reaction (to close) | +0.57% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 ESLA earnings events with a measured close landed between -2.37% and +4.09%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Estrella Immunopharma, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.14% | |
| Form 10-Q Estrella Immunopharma, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.61% | |
| Form NT 10-Q Estrella Immunopharma, For: Mar 31 | SEC filing · Form NT | +0.00% | -2.61% | |
| Form 10-K/A Estrella Immunopharma, For: Dec 31 | SEC filing · Form 10-K | -2.51% | +1.24% | |
| Form 10-K Estrella Immunopharma, For: Dec 31 | SEC filing · Form 10-K | +3.64% | -1.82% | |
| Form 10-Q Estrella Immunopharma, For: Sep 30 | SEC filing · Form 10-Q | -1.66% | — | |
| Form 10-Q Estrella Immunopharma, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Estrella Immunopharma, For: Mar 31 | SEC filing · Form 10-Q | -4.13% | -8.73% | |
| Form 10-Q Estrella Immunopharma, For: Sep 30 | SEC filing · Form 10-Q | — | +18.46% | |
| Form 10-K/A Estrella Immunopharma, For: Jun 30 | SEC filing · Form 10-K | +6.74% | +0.57% | |
| Form 10-K Estrella Immunopharma, For: Jun 30 | SEC filing · Form 10-K | — | +22.69% | |
| Form 10-Q Estrella Immunopharma, For: Mar 31 | SEC filing · Form 10-Q | — | +6.93% | |
| Form 10-Q Estrella Immunopharma, For: Dec 31 | SEC filing · Form 10-Q | — | +0.93% |
Keep exploring
More ESLA: analyst actions → · SEC filings → · ESLA overview →